AbbVie (ABBV) FCF Margin (2012 - 2026)
AbbVie (ABBV) recorded FCF Margin of 41.97% in Q3 2026, down 0.14 percentage points from 42.11% a year earlier but up 23.64 percentage points from the prior quarter.
AbbVie (ABBV) FCF Margin (2012 - 2026) Analysis & Trends
On a TTM basis, AbbVie's FCF Margin came in at 28.59% as of Sep 30, 2026, down 4.41 percentage points year-over-year; for FY2025, it came in at 29.13%, down 2.52 percentage points from FY2024.
- Annual FCF Margin has declined for three straight years, with a five-year change of -7.53 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at 31.65% in FY2024 (-8.96 pp), 40.62% in FY2023 (-1.15 pp), 41.77% in FY2022 (+2.64 pp) and 39.13% in FY2021 (+2.47 pp).
- Quarterly FCF Margin has ranged from 10.49% in Q1 2025 to 52.81% in Q3 2023 over the past five years.
- On a year-over-year basis, FCF Margin rose in four of the last eight quarters, with an average year-over-year change of +0.06 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 17.63 percentage points in Q2 2025, against a drop of 30.25 percentage points in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 18.33% (Q2 2026), 23.76% (Q1 2026) and 29.42% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 28.96% |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 15.86% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 41.97% |
| Jun 30, 2026 | 18.33% |
| Mar 31, 2026 | 23.76% |
| Dec 31, 2025 | 29.42% |
| Sep 30, 2025 | 42.11% |
| Jun 30, 2025 | 31.67% |
| Mar 31, 2025 | 10.49% |
| Dec 31, 2024 | 44.74% |
| Sep 30, 2024 | 35.95% |
| Jun 30, 2024 | 14.04% |
| Mar 31, 2024 | 31.25% |
| Dec 31, 2023 | 31.80% |
| Sep 30, 2023 | 52.81% |
| Jun 30, 2023 | 44.29% |
| Mar 31, 2023 | 32.87% |
| Dec 31, 2022 | 47.72% |
| Sep 30, 2022 | 50.13% |
| Jun 30, 2022 | 33.34% |
| Mar 31, 2022 | 35.06% |
| Dec 31, 2021 | 32.84% |
AbbVie FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();